Which prophylactic drug is expected to be prescribed for a patient with cardiac disease?

In patients with cardiac disease, especially those at risk for thromboembolic events or with a history of such conditions, the use of heparin is particularly relevant. Heparin is an anticoagulant that helps prevent the formation of blood clots. It is commonly used in settings where immediate anticoagulation is needed, such as during pregnancy for women with specific cardiac conditions or those who may be at elevated risk for deep vein thrombosis (DVT) or pulmonary embolism (PE).

In this context, heparin is typically preferred because it has a rapid onset of action and can be closely monitored through regular blood tests, allowing for quick adjustments based on individual patient needs. It is also safe to use in pregnant patients, which is a significant consideration for those with cardiac disease during pregnancy.

Other options, while also important in cardiovascular care, serve different purposes or have different implications for use in cardiac disease. Aspirin might be used for its antiplatelet effects in certain populations but is not categorized strictly as a prophylactic for those with significant cardiac disease. Warfarin is a longer-acting anticoagulant that requires careful monitoring and is not generally first-line, especially in the setting of acute care or in vitamin K-sensitive